Targeted immune modulators not cost effective in ulcerative colitis

  • PDF / 167,319 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 89 Downloads / 193 Views

DOWNLOAD

REPORT

-5503/20/0863-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 3 Oct 2020 No. 863

1

Data Loading...

Recommend Documents
Ulcerative Colitis

148 55 566KB

Ulcerative Colitis

162 59 57MB

Ulcerative Colitis: Surgical Management

164 98 2MB

Ulcerative colitis exacerbation after the onset of immune checkpoint inhibitor related colitis

176 94 2MB

Bevacizumab + capecitabine not cost effective in mCRC

162 48 111KB

Natural History of Ulcerative Colitis in Children

168 107 13MB

Medical Management of Chronic Ulcerative Colitis

151 84 2MB

Ivacaftor not cost effective in cystic fibrosis with G551D mutation

163 21 182KB

Pouch failures following restorative proctocolectomy in ulcerative colitis

146 44 275KB

Anti-inflammatory effects of nicotine in obesity and ulcerative colitis

150 82 488KB

IBD: Management of Dysplasia in Patients with Ulcerative Colitis

182 34 246KB

Patient-initiated DMARD self-monitoring service not cost effective

190 97 167KB